copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home Page - pluri-biotech. com Pluri’s three-dimensional (3D) cell expansion platforms grow cells in an efficient and cost-effective process This process can be applied to many different cell types, from plant to animal and human cells Pluri is a global leader in 3D cell-expansion technology, developing platforms to manufacture the products and solutions of the future
Pluri CEO Issues Shareholder Update - pluri-biotech. com Pluri’s method is uniquely accurate, scalable, cost-effective, and consistent from batch to batch Pluri currently operates in the field of regenerative medicine and food-tech and aims to establish partnerships that leverage the Company’s 3D cell-based technology to additional industries that require effective, mass cell production
CORPORATE PRESENTATION - pluri-biotech. com The Pluri technology platforms leverage the basic building blocks of life—cells—to create medicine, food and cell-based materials that can change the course of human history
Team Archive - pluri-biotech. com Zalts joined Pluri from Matics Manufacturing Analytics Ltd , a SaaS, high-tech company based in Israel, where she served as CFO Before Matics, Mrs Zalts worked at Ernst Young Israel (EY) and served as a manager of audit groups relating to public and private companies in the high-tech department
Pluristem Announces Clearance to Move Forward with Enrollment for . . . Pluri Biotech Ltd is committed to making its electronic and information technologies accessible to individuals with disabilities by meeting or exceeding the requirements of the Web Content Accessibility Guidelines and we make every effort to ensure our communications – including this website – are accessible to people with special needs
SOCIAL IMPACT REPORT - pluri-biotech. com Pluri aims to become a global leader in this space through its joint venture with Israel’s largest food producer, Tnuva Group The joint venture, Ever After Foods, uses Pluri’s knowhow and breakthrough PluriMatrix technology to overcome scaling and eficiency challenges that have historically hindered cultivated meat from reaching scale
ABOUT CDMO - pluri-biotech. com ABOUT Since 2003, Pluri has been a global leader in the field of cell therapy and has advanced potential therapeutics through preclinical to Phase I, Phase II and Phase III clinical development Over the past two decades, we have cultivated a wealth of experience in process and analytical development, process scale-up, validation, logistics and automation […]
Pluri s Sustainable Cell-Based Coffee Addresses Critical Challenges . . . Pluri’s cell-based coffee aims to reduce price instability by moving coffee production into the lab, eliminating the effect of climate change and adverse weather conditions Pluri recently announced the launch of its cell-based coffee, its proprietary cultured coffee product business, part of its PluriAgtech vertical, addressing the $130 billion coffee industry The Company’s cell
INVESTOR PRESENTATION - pluri-biotech. com The Pluri technology platforms leverage the basic building blocks of life—cells—to create medicine, food and cell-based materials that can change the course of human history
INVESTORS ESG - pluri-biotech. com INVESTORS PLURI’S 3DCELL-BASEDTECHNOLOGYINVESTORS ESG NASDAQ: PLUR TASE ISRAEL: PLUR NASDAQ: PLUR TASE ISRAEL: PLUR ABOUT PLURI Pluri Inc is pushing the boundaries of science and engineering to create cell-based products for commercial use and is pioneering a biotech revolution that promotes global wellbeing and sustainability The Company’s technology platform, a patented and validated